Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CStone's MEK Inhibitor CS3006 Receives IND Approval in China 2018-07-30 12:51
China Biologic Products to Report Second Quarter 2018 Financial Results 2018-07-27 20:00
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator 2018-07-26 19:30
WuXi STA's Jinshan Site Passes Fourth U.S. FDA Inspection 2018-07-26 08:00
OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing 2018-07-23 14:42
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China 2018-07-22 22:11
Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia 2018-07-19 21:00
China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing 2018-07-17 19:00
SK Holdings to Acquire AMPAC Fine Chemicals (AFC), a Leading Contract Development and Manufacturing Organization (CDMO) 2018-07-12 16:59
AGC to Expand GMP-Compliant Synthetic Pharmaceutical Intermediate and Active Ingredient Production Capacity Tenfold 2018-07-12 13:00
US FDA Approves Adagene IO Agonist IND for Solid Tumor and Non-Hodgkin Lympoma Ph1 Trial 2018-07-10 08:08
CHINA AID, one of the most authoritative elderly and long-term care events in China 2018-07-03 01:00
China Biologic Announces Results of Its 2018 Annual General Meeting of Shareholders 2018-07-02 20:30
Top 50 In Global Pharma By 2025 -- Luye Pharma Group Announces "Whole Value Chain" Global Collaboration Strategy 2018-06-25 13:35
PharmaEngine Announces Positive Topline Results from Global Pivotal Trial of PEP503 (NBTXR3) in Soft Tissue Sarcoma 2018-06-22 08:07
TOT BIOPHARM's 16,000L-capacity monoclonal antibodies production base put into operation 2018-06-21 10:40
CStone enrolls first patient in Phase I study for MEK inhibitor CS3006 in Australia 2018-06-20 19:07
Luye Pharma Bolsters Its Global Analgesics Portfolio with China Class 1.1 New Compound LY03012 to Start Phase I Clinical Trials 2018-06-19 21:52
China Biologic Announces Receipt of Non-Binding Acquisition Proposal 2018-06-19 20:00
Alpha Biopharma Announces Series A Financing 2018-06-19 17:36
1 132 133 134 135 136 158